Pattern of relapse in childhood all: Challenges and lessons from a uniform treatment protoco

Journal of Pediatric Hematology/Oncology

Volumn 32, Issue 5, 2010, Pages 370-375

  Arya, Laxman Singh ^a,d   Kotikanyadanam, S P ^a   Bhargava, Manorama ^b   Saxena, Renu ^b   Sazawal, Sudha ^b   Bakhshi, Sameer ^c   Khattar, Anshu ^b   Kulkarni, Ketan P ^d   Adde, Melissa ^e   Vats, Trib S ^f   Magrath, Ian ^e  

^a Department of Pediatrics   (India)

^b Department of Hematology ^*  (India)

^c INSTITUTE ROTARY CANCER HOSPITAL   (India)

^d INDRAPRASTHA APOLLO HOSPITAL   (India)

^e INTERNATIONAL NETWORK FOR CANCER TREATMENT AND RESEARCH   (Belgium)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Acute lymphoblastic leukemia; Children; Prognostic factors; Relapse; Survival outcome

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; HYDROCORTISONE; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW CANCER; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RELAPSE; CANCER RISK; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CHILDHOOD LEUKEMIA; COHORT ANALYSIS; FEMALE; HIGH RISK POPULATION; HUMAN; LEUKOCYTE COUNT; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX RATIO; TESTIS CANCER; BRAIN TUMOR; INFANT; MORTALITY; MULTIMODALITY CANCER THERAPY; RADIATION DOSE; REMISSION; SURVIVAL RATE; TESTIS TUMOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW NEOPLASMS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INFANT; MALE; NEOPLASM RECURRENCE, LOCAL; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TESTICULAR NEOPLASMS; TREATMENT OUTCOME;

EID: 77955913437     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181d7ae0d     Document Type: Article

References (35)

1. Gaynon PS. Childhood acute lymphoblastic leukemia and relapse. Br J Haematol. 2005;131: 579-587.
2. Eden OB. Translation of cure for acute lymphoblastic leukemia to all children. Br J Hematol. 2002;118: 945-951.
3. Chessells JM. Recent advances in the management of acute leukemia. Arch Dis Child. 2000;82: 438-442.
4. Bleyer WA. Acute lymphoblastic leukemia in children: Advances and prospectus. Cancer. 1990;65: 689-695.
5. Vrooman LM, Silverman LB. Childhood acute lymphoblastic leukemia: update on prognostic factors. Curr Opin Pediatr. 2009;21: 1-8.
6. Pui CH, Sandlund JT, Pei D. Results of therapy for acute lymphoblastic leukemia in black and white children. JAMA. 2003;290: 2001-2007.
7. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med. 2006;354: 166-178.
8. Pullen J, Shuster JJ, Link M. Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. Leukemia. 1999;13: 1696-1707.
9. Pui CH, Schrappe M, Ribeiro MC, et al. Childhood and adolescent lymphoid and myeloid leukemia. Hematology. 2004;1: 118-145.
10. Schrappe M. Prognostic factors in childhood ALL. Ind J Pediatr. 2003;70: 817-824.
11. Pui CH. Acute lymphoblastic leukemia in children. Curr Opin Oncol. 2000;12: 3-12.
12. Shanta V, Maitreyan V, Sagar TG, et al. Prognostic variables and survival in pediatric acute lymphoblastic leukemias: Cancer institute experience. Pediatr Hematol Oncol. 1996;13: 205-216.
13. Vaidya SJ, Advani SH, Pai SK, et al. Survival of childhood acute lymphoblastic leukemia: results of therapy at Tata Memorial Hospital, Bombay, India. Leuk Lymphoma. 1996;20: 311-315.
14. Magrath I, Shanta V, Advani S, et al. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period. Eur J Cancer. 2005;41: 1570-1583.
15. Advani SH, Rao DN, Gopal R, et al. Acute lymphoblastic leukemia: end-result analysis of treatment and prognostic factors in Indian patients. Am J Hematol. 1983;15: 35-43.
16. Advani SH, Iyer RS, Pai SK, et al. Four-agent induction/consolidation therapy for childhood acute lymphoblastic leukemia: An Indian experience. Am J Hematol. 1992: 39;242-248.
17. Advani S, Pai S, Venzon D, et al. Acute lymphoblastic leukaemia in India: An analysis of prognostic factors using a single treatment regimen. Ann Oncol. 1999;10: 167-176.
18. Malempati S, Gaynon PS, Sather H, et al. Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG-19J Clin Oncol. 2007;25: 5800-5807.
19. Silverman LB, Gelber RD, Dalton VK, et al. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-Blood. 2001;97: 1211-1218.
20. Kadan-Lottick NS, Ness KK, Bhatia S, et al. Survival variability by race and ethnicity in childhood ALL. JAMA. 2003;290: 2008-2014.
21. Schrappe A, Reiter A, Zimmerman M, et al. Long term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981-19Leukemia. 2000;14: 2205-2222.
22. Eden OB, Harrison G, Richard S, et al. Long term follow up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukemia. Leukemia. 2000;14: 2307-2320.
23. Schrappe M, Reiter A, Ludwig WD, et al. Improved outcome in childhood ALL despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM Blood. 2000;95: 3310-3322.
24. Pui CH, Mahmoud HH, Rivera GK, et al. Early intensification of intrathecal chemotherapy virtually eliminates cranial nervous system relapse in children with acute lymphoblastic leukemia. Blood. 1998;92: 411-415.
25. Pui CH. Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment. Hematology Am Soc Hematol Educ program. 2006;142-146.
26. Gunyon PS, Qu RP, Chappel RJ, et al. Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse. Cancer. 1998;82: 1387-1395.
27. Te Loo DM, Kamps WA, Does-van den Berg AV, et al. Prognostic significance of blasts in the cerebrospinal fluid without pleocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: The experience of the Dutch Childhood Oncology Group. J Clin Oncol. 2006;24: 2332-2336.
28. Gilchrist GS, Tubergen DG, Sather HN, et al. Low numbers of CSF blasts at diagnosis do not predict for the development of CNS leukemia in children with intermediate-risk acute lymphoblastic leukemia: A Children's Cancer Group report. J Clin Oncol. 1994;12: 2594-2600.
29. Bürger B, Zimmermann M, Mann G, et al. Diagnostic cerebrospinal fluid (CSF) examination in children with acute lymphoblastic leukemia (ALL): significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol. 2003;21: 184-188.
30. Brecher ML, Weinberg V, Boyett JM, et al. Intermediate dose methotrexate in childhood acute lymphoblastic leukemia resulting in decreased incidence of testicular relapse. Cancer. 1986;58: 1024-1028.
31. Dordelmann M, Reiter A, Zimmermann M, et al. Intermediate dose methotrexate is as effective as high dose methotrexate in preventing isolated testicular relapse in childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 1998;20: 444-450.
32. Derwich K, Kaczmarek-Kanold M, Wachowiak J, et al. Treatment results in children with standard-risk acute lympho-blastic leukemia. Report of the Polish Pediatric Leukemia/ Lymphoma Study Group. Przegl Lek. 2004;61: 49-52.
33. Sazawal S, Bhatia K, Gutierrez MI, et al. Paucity of TEL-AML1 translocation by multiplex RT-PCR in B-lineage acute lymphoblastic leukemia in Indian patients. Am J Hematol. 2004;76: 80-82.
34. Horibe K, Hara J, Yagi K, et al. Prognostic factors in child hood acute lymphoblastic leukemia in Japan. Int J Hematol. 2000;72: 61-68.
35. Kulkarni KP, Marwaha RK, Trehan A, et al. Survival outcome in childhood all: experience from a tertiary care centre in North India. Pediatr Blood Cancer. 2009;53: 168-173.